Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

Rhea-AI Summary

Evolent Health (NYSE: EVH) has announced it will release its Q4 2024 financial results on Thursday, February 20, 2025, after market close, followed by a conference call at 5 p.m. ET. Shareholders and analysts can access the live broadcast through Evolent's investor relations website, with analysts able to participate by dialing specific numbers.

The company also announced its executive management team's participation in three upcoming investor conferences in March 2025: the Cowen 45th Annual Health Care Conference in Boston on March 4, the Oppenheimer 35th Annual Health Care MedTech and Services Conference virtually on March 17, and the KeyBanc Annual Health Care Forum virtually on March 19. Audio webcasts will be available on Evolent's investor relations website.

News Market Reaction

+4.41%

1 alert

+4.41% News Effect

On the day this news was published, EVH gained 4.41%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Company to Participate in Upcoming Conferences

WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its fourth quarter 2024 financial results on Thursday, February 20, 2025, after market close, with a conference call to follow at 5 p.m. ET.

Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.

Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.

An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.

Upcoming Investor Events

Additionally, Evolent announced that its executive management team will participate in upcoming investor conferences.

A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.   

• Cowen 45^th Annual Health Care Conference at the Boston Marriot Copley Place in Boston, Massachusetts on March 4, 2025.
  
  
• Oppenheimer 35^th Annual Health Care MedTech and Services Conference to be held virtually on March 17, 2025.
  
  
• KeyBanc Annual Health Care Forum to be held virtually on March 19, 2025.

About Evolent 

Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.

Contacts:

Seth R. Frank
Vice President, Investor Relations
Evolent
sfrank@evolent.com
571-895-3919 (W)

View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-fourth-quarter-2024-financial-results-on-thursday-february-20-2025-302361260.html

SOURCE Evolent Health, Inc.

FAQ

When will Evolent Health (EVH) release Q4 2024 earnings?

Evolent Health will release its Q4 2024 financial results on Thursday, February 20, 2025, after market close.

What time is Evolent Health's (EVH) Q4 2024 earnings call?

The earnings conference call will be held at 5 p.m. ET on Thursday, February 20, 2025.

Which investor conferences will EVH attend in March 2025?

EVH will attend the Cowen Annual Health Care Conference in Boston on March 4, the Oppenheimer Health Care Conference virtually on March 17, and the KeyBanc Health Care Forum virtually on March 19, 2025.

How can investors access EVH's Q4 2024 earnings call?

Investors can access the live broadcast through Evolent's investor relations website at ir.evolent.com, or analysts can dial 855.940.9467 (412.317.6034 for international callers).